Targeting TREM2 on tumor-associated macrophages enhances immunotherapy
Author(s) -
Mikhail Binnewies,
Joshua L. Pollack,
Joshua Rudolph,
Subhadra Dash,
Marwan Abushawish,
Tian Lee,
Nadine S. Jahchan,
Pamela S. Canaday,
Erick Lu,
Manith Norng,
Shilpa Mankikar,
Victoria M. Liu,
Xiaoyan Du,
Amanda Chen,
Ranna Mehta,
Rachael Palmer,
Vladislava Juric,
Linda Liang,
Kevin P. Baker,
Leonard Reyno,
Matthew F. Krummel,
Michel Streuli,
Venkataraman Sriram
Publication year - 2021
Publication title -
cell reports
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2021.109844
Subject(s) - tumor microenvironment , immunotherapy , cancer research , cd8 , cancer immunotherapy , monoclonal antibody , ovarian cancer , immunology , tumor infiltrating lymphocytes , trem2 , medicine , cancer , biology , immune system , antibody , myeloid cells
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom